Cargando…

Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products

Dry eye syndrome (DES) is a multifactorial, frequent, pathology characterized by deficient tear production or increased evaporation of tears and associated with ocular surface alteration and inflammation. It mostly affects, but not exclusively, older individuals and leads to varying degrees of disco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drew, Victor J., Tseng, Ching-Li, Seghatchian, Jerard, Burnouf, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829051/ https://www.ncbi.nlm.nih.gov/pubmed/29527528 http://dx.doi.org/10.3389/fmed.2018.00033

Ejemplares similares

Ebola virus convalescent blood products: Where we are now and where we may need to go
por: Burnouf, Thierry, et al.
Publicado: (2014)

“Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed!
por: Burnouf, Thierry, et al.
Publicado: (2014)

Platelet and extracellular vesicles in COVID-19 infection and its vaccines
por: Goubran, Hadi, et al.
Publicado: (2022)

SARS-CoV-2 and cancer: the intriguing and informative cross-talk
por: Goubran, Hadi, et al.
Publicado: (2022)

Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome
por: Tseng, Ching-Li, et al.
Publicado: (2016)

Impact of Transfusion on Cancer Growth and Outcome
por: Goubran, Hadi A., et al.
Publicado: (2016)

In vitro mass production of reproducible human cells destined for substitution therapy: Challenges for development of functional materials for what we need most in transfusion!
por: Seghatchian, Jerard
Publicado: (2020)

The secrets of human stem cell-derived transfusable RBC for targeted large-scale production and clinical applications: A fresh look into what we need most and lessons to be learned
por: Seghatchian, Jerard
Publicado: (2020)

An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research
por: Putter, Jeffrey S., et al.
Publicado: (2020)

Editorial: Dry eye disease syndrome
por: Navas, Alejandro, et al.
Publicado: (2023)

Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes
por: Amiral, Jean, et al.
Publicado: (2023)

Updates on Stem Cell Therapy in Transfusion Medicine, New Approaches to RBC Substitution Therapy, the Use of IFC for the Assessment of Extracellular- Derived Vesicles/Exosomes
por: Seghatchian, Jerard
Publicado: (2020)

Facts and challenges on global deployment of vaccines for the immunotherapy of the evolving SARS Cov-2 variants: What a new year, with a fast spreading South African and the most fearful Brazilian variants, as the unwanted gifts, imposing enormous crises to surmount
por: Seghatchian, Jerard
Publicado: (2021)

New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic
por: Seghatchian, Jerard
Publicado: (2021)

Editorial: Time to explore the missing links: from activated platelets and platelet extracellular vesicles in SARS-CoV-2 infection, through heterogeneity in the host physiological, immuno-inflammatory and haemostatic responses to mRNA-based vaccine or infection induced polyclonal neutralizing antibodies and passive immunity
por: Seghatchian, Jerard
Publicado: (2022)

Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
por: Seghatchian, Jerard
Publicado: (2022)

Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes
por: Seghatchian, Jerard
Publicado: (2022)

Spotlight on SARS CoV-2 infection inducing autoimmunity, through the formation of autoantibody to self hemostatic components or to host cells, often leading to severe thrombotic or bleeding events
por: Seghatchian, Jerard
Publicado: (2023)

Herbal Supplement in a Buffer for Dry Eye Syndrome Treatment
por: Chen, Hung-Chang, et al.
Publicado: (2017)

Trends and targets of various types of stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity
por: Lanza, Francesco, et al.
Publicado: (2020)

T-cell lymphocytopenia: An omnipresent predictor of morbidity and mortality in consequence of SARS-CoV disease and influenza A infections
por: Putter, Jeffrey S., et al.
Publicado: (2023)

Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders
por: Lanza, Francesco, et al.
Publicado: (2021)

Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
por: Belem, Wendimi Fatimata, et al.
Publicado: (2022)

On the Quest for In Vitro Platelet Production by Re-Tailoring the Concepts of Megakaryocyte Differentiation
por: Martínez-Botía, Patricia, et al.
Publicado: (2020)

Cell culture – Fact and fiction
por: Smit Sibinga, Cees Th., et al.
Publicado: (2020)

Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron
por: Seghatchian, Jerard, et al.
Publicado: (2022)

Analysis of Conjunctival Sac Microbiome in Dry Eye Patients With and Without Sjögren's Syndrome
por: Song, Hang, et al.
Publicado: (2022)

Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!!
por: Seghatchian, Jerard, et al.
Publicado: (2020)

Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?
por: Amiral, Jean, et al.
Publicado: (2020)

Therapeutic Effects of Topical Application of Lycium barbarum Polysaccharide in a Murine Model of Dry Eye
por: Qin, Danyi, et al.
Publicado: (2022)

Ocular Surface Inflammatory Disorders (OSID): A Collective of Systemic Etiologies Which Cause or Amplify Dry Eye Syndrome
por: Soifer, Matias, et al.
Publicado: (2022)

Ocular Surface Ion-Channels Are Closely Related to Dry Eye: Key Research Focus on Innovative Drugs for Dry Eye
por: Yang, Shuo, et al.
Publicado: (2022)

Advances in Dry Eye Disease Examination Techniques
por: Wu, Yaying, et al.
Publicado: (2022)

Development of Lutein-Containing Eye Drops for the Treatment of Dry Eye Syndrome
por: Chen, Yi-Zhou, et al.
Publicado: (2021)

Changes of Dry Eye Parameters Especially Meibomian Gland Functions After Punctal Plugs Insertion in Aqueous-Deficient Dry Eye Patients
por: Liu, Tingting, et al.
Publicado: (2022)

Application of Animal Models in Interpreting Dry Eye Disease
por: Zhu, Jun, et al.
Publicado: (2022)

Effect of multivitamin drug on intractable dry eye symptoms
por: Park, Se Hie, et al.
Publicado: (2022)

Quantum molecular resonance electrotherapy (Rexon-Eye) for recalcitrant dry eye in an Asian population
por: Foo, Valencia Hui Xian, et al.
Publicado: (2023)

Cataract Surgery in Dry Eye Disease: Visual Outcomes and Complications
por: Donthineni, Pragnya R., et al.
Publicado: (2020)

Editorial: Advances in the Pathophysiology, Diagnosis, and Treatment of Dry Eye Disease
por: Lu, Yiteng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n7kl45nkq7p9uk5hat9a5o0qri